US Stock MarketDetailed Quotes

PBLA Panbela Therapeutics

Watchlist

0.349
-0.008-2.34%

15min DelayClose Nov 22 16:00 ET

1.70MMarket Cap-10P/E (TTM)

Panbela Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

68.25%-2.12M

82.91%-981K

3.68%-9.39M

-65.29%-25.25M

38.44%-3.08M

-319.15%-6.68M

-36.79%-5.74M

-117.51%-9.75M

-110.85%-15.28M

-124.55%-5M

Net income from continuing operations

8.41%-7.18M

-22.30%-7.14M

-39.25%-7.12M

27.68%-25.26M

-36.73%-6.47M

-78.06%-7.84M

73.62%-5.84M

-39.47%-5.11M

-244.68%-34.93M

-33.83%-4.74M

Operating gains losses

--0

----

---400K

--0

----

Other non cash items

570.77%436K

-18.46%53K

-19.05%34K

-12.82%238K

-62.50%66K

-22.62%65K

--65K

--42K

--273K

--176K

Change In working capital

253.98%4.62M

2,416.84%6.88M

50.43%-2.41M

-215.74%-647K

574.67%3.2M

-47.66%1.31M

-170.00%-297K

-322.24%-4.86M

-65.13%559K

-169.30%-675K

-Change in receivables

--0

---140K

-162.26%-132K

77.78%-20K

-88.96%37K

---149K

--0

315.69%212K

-135.71%-90K

-Change in prepaid assets

-102.86%-74K

194.99%816K

56.74%-912K

-100.74%-5.4M

-124.18%-5.02M

1,214.66%2.59M

-135.34%-859K

20.45%-2.11M

-817.41%-2.69M

-335.21%-2.24M

-Change in payables and accrued expense

121.34%281K

635.51%5.97M

-150.46%-1.36M

60.82%4.88M

396.81%2.7M

-155.06%-1.32M

3,955.00%811K

75.52%2.69M

64.50%3.04M

-173.54%-909K

-Change in other current assets

--4.42M

200.00%100K

--0

----

--0

---100K

---5.44M

----

Cash from discontinued investing activities

Operating cash flow

68.25%-2.12M

82.91%-981K

3.68%-9.39M

-65.29%-25.25M

38.44%-3.08M

-319.15%-6.68M

-36.79%-5.74M

-117.51%-9.75M

-110.85%-15.28M

-124.55%-5M

Investing cash flow

Cash flow from continuing investing activities

160.98%400K

40,100.00%400K

-656K

Net intangibles purchase and sale

--0

----

160.61%400K

--0

40,100.00%400K

----

---660K

--0

Net business purchase and sale

----

--0

----

--4K

--0

Cash from discontinued investing activities

Investing cash flow

--0

----

160.98%400K

--0

40,100.00%400K

----

---656K

--0

Financing cash flow

Cash flow from continuing financing activities

11,678.95%2.2M

-48.32%7.08M

388.27%26.14M

-11.22%4.75M

-480.00%-19K

7.71M

13.7M

-46.97%5.35M

534,800.00%5.35M

Net issuance payments of debt

--2.2M

--0

39.39%-1M

---1.65M

--0

---1.65M

--0

Net common stock issuance

--0

-47.36%8.08M

330.79%23.04M

-100.17%-9K

---19K

--7.72M

--15.35M

-40.92%5.35M

534,800.00%5.35M

Proceeds from stock option exercised by employees

----

94,880.00%4.75M

----

-99.52%5K

--0

Net other financing activities

----

--0

----

Cash from discontinued financing activities

Financing cash flow

11,678.95%2.2M

--0

-48.32%7.08M

388.27%26.14M

-11.22%4.75M

-480.00%-19K

--7.71M

--13.7M

-46.97%5.35M

534,800.00%5.35M

Net cash flow

Beginning cash position

-99.18%59K

-95.00%262K

100.62%2.58M

-89.17%1.29M

-3.61%907K

184.78%7.21M

-29.12%5.24M

-89.17%1.29M

31.53%11.87M

-93.31%941K

Current changes in cash

101.27%80K

-110.47%-206K

-158.44%-2.31M

112.22%1.29M

382.37%1.67M

-296.22%-6.3M

140.54%1.97M

188.18%3.95M

-471.03%-10.58M

115.54%346K

Effect of exchange rate changes

250.00%3K

0.00%3K

-100.00%-6K

--0

200.00%2K

---2K

175.00%3K

-250.00%-3K

33.33%-4K

-109.09%-2K

End cash Position

-84.34%142K

-99.18%59K

-95.00%262K

100.62%2.58M

-3.61%907K

184.78%7.21M

-29.12%5.24M

-89.17%1.29M

Free cash flow

68.25%-2.12M

82.91%-981K

3.68%-9.39M

-58.44%-25.25M

38.44%-3.08M

-318.88%-6.68M

-18.22%-5.74M

-117.51%-9.75M

-119.96%-15.94M

-124.55%-5M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	68.25%-2.12M	82.91%-981K	3.68%-9.39M	-65.29%-25.25M	38.44%-3.08M	-319.15%-6.68M	-36.79%-5.74M	-117.51%-9.75M	-110.85%-15.28M	-124.55%-5M
Net income from continuing operations	8.41%-7.18M	-22.30%-7.14M	-39.25%-7.12M	27.68%-25.26M	-36.73%-6.47M	-78.06%-7.84M	73.62%-5.84M	-39.47%-5.11M	-244.68%-34.93M	-33.83%-4.74M
Operating gains losses	--0	----	----	---400K	--0	----	----	----	----	----
Other non cash items	570.77%436K	-18.46%53K	-19.05%34K	-12.82%238K	-62.50%66K	-22.62%65K	--65K	--42K	--273K	--176K
Change In working capital	253.98%4.62M	2,416.84%6.88M	50.43%-2.41M	-215.74%-647K	574.67%3.2M	-47.66%1.31M	-170.00%-297K	-322.24%-4.86M	-65.13%559K	-169.30%-675K
-Change in receivables	--0	--0	---140K	-162.26%-132K	77.78%-20K	-88.96%37K	---149K	--0	315.69%212K	-135.71%-90K
-Change in prepaid assets	-102.86%-74K	194.99%816K	56.74%-912K	-100.74%-5.4M	-124.18%-5.02M	1,214.66%2.59M	-135.34%-859K	20.45%-2.11M	-817.41%-2.69M	-335.21%-2.24M
-Change in payables and accrued expense	121.34%281K	635.51%5.97M	-150.46%-1.36M	60.82%4.88M	396.81%2.7M	-155.06%-1.32M	3,955.00%811K	75.52%2.69M	64.50%3.04M	-173.54%-909K
-Change in other current assets	--4.42M	200.00%100K	--0	----	----	--0	---100K	---5.44M	----	----
Cash from discontinued investing activities
Operating cash flow	68.25%-2.12M	82.91%-981K	3.68%-9.39M	-65.29%-25.25M	38.44%-3.08M	-319.15%-6.68M	-36.79%-5.74M	-117.51%-9.75M	-110.85%-15.28M	-124.55%-5M
Investing cash flow
Cash flow from continuing investing activities	0			160.98%400K	0	40,100.00%400K			-656K	0
Net intangibles purchase and sale	--0	----	----	160.61%400K	--0	40,100.00%400K	----	----	---660K	--0
Net business purchase and sale	----	----	----	--0	----	----	----	----	--4K	--0
Cash from discontinued investing activities
Investing cash flow	--0	----	----	160.98%400K	--0	40,100.00%400K	----	----	---656K	--0
Financing cash flow
Cash flow from continuing financing activities	11,678.95%2.2M	0	-48.32%7.08M	388.27%26.14M	-11.22%4.75M	-480.00%-19K	7.71M	13.7M	-46.97%5.35M	534,800.00%5.35M
Net issuance payments of debt	--2.2M	--0	39.39%-1M	---1.65M	--0	--0	--0	---1.65M	--0	--0
Net common stock issuance	--0	--0	-47.36%8.08M	330.79%23.04M	-100.17%-9K	---19K	--7.72M	--15.35M	-40.92%5.35M	534,800.00%5.35M
Proceeds from stock option exercised by employees	----	----	----	94,880.00%4.75M	----	----	----	----	-99.52%5K	--0
Net other financing activities	----	----	----	----	----	--0	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	11,678.95%2.2M	--0	-48.32%7.08M	388.27%26.14M	-11.22%4.75M	-480.00%-19K	--7.71M	--13.7M	-46.97%5.35M	534,800.00%5.35M
Net cash flow
Beginning cash position	-99.18%59K	-95.00%262K	100.62%2.58M	-89.17%1.29M	-3.61%907K	184.78%7.21M	-29.12%5.24M	-89.17%1.29M	31.53%11.87M	-93.31%941K
Current changes in cash	101.27%80K	-110.47%-206K	-158.44%-2.31M	112.22%1.29M	382.37%1.67M	-296.22%-6.3M	140.54%1.97M	188.18%3.95M	-471.03%-10.58M	115.54%346K
Effect of exchange rate changes	250.00%3K	0.00%3K	-100.00%-6K	--0	200.00%2K	---2K	175.00%3K	-250.00%-3K	33.33%-4K	-109.09%-2K
End cash Position	-84.34%142K	-99.18%59K	-95.00%262K	100.62%2.58M	100.62%2.58M	-3.61%907K	184.78%7.21M	-29.12%5.24M	-89.17%1.29M	-89.17%1.29M
Free cash flow	68.25%-2.12M	82.91%-981K	3.68%-9.39M	-58.44%-25.25M	38.44%-3.08M	-318.88%-6.68M	-18.22%-5.74M	-117.51%-9.75M	-119.96%-15.94M	-124.55%-5M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data